Sight Sciences (SGHT) EPS (Diluted) Growth (1y) (2022 - 2026)
Sight Sciences (SGHT) EPS (Diluted) Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -47.60% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 44.49% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 15.24% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -25.88% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 44.97% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 71.72% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 13.96% |
| 10 | Sight Sciences | 448.86 Mn | 369.10 Mn | 21.37 Mn | 64.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 64.60% |
| Mar 31, 2026 | 12.80% |
| Dec 31, 2025 | 66.22% |
| Sep 30, 2025 | 29.05% |
| Jun 30, 2025 | 6.73% |
| Mar 31, 2025 | 16.05% |
| Dec 31, 2024 | -7.48% |
| Sep 30, 2024 | 17.92% |
| Jun 30, 2024 | 18.73% |
| Mar 31, 2024 | 6.78% |
| Dec 31, 2023 | 37.78% |
| Sep 30, 2023 | 42.28% |
| Jun 30, 2023 | 39.18% |
| Mar 31, 2023 | 27.90% |
| Dec 31, 2022 | 40.72% |
| Sep 30, 2022 | -7.69% |